Literature DB >> 33274614

Origin, evolution and global spread of SARS-CoV-2.

Anna Zhukova1,2,3, Luc Blassel2,3, Frédéric Lemoine1,2,3, Marie Morel2,3, Jakub Voznica2,3, Olivier Gascuel3.   

Abstract

SARS-CoV-2 is the virus responsible for the global COVID19 pandemic. We review what is known about the origin of this virus, detected in China at the end of December 2019. The genome of this virus mainly evolves under the effect of point mutations. These are generally neutral and have no impact on virulence and severity, but some appear to influence infectivity, notably the D614G mutation of the Spike protein. To date (30/09/2020) no recombination of the virus has been documented in the human host, and very few insertions and deletions. The worldwide spread of the virus was the subject of controversies that we summarize, before proposing a new approach free from the limitations of previous methods. The results show a complex scenario with, for example, numerous introductions to the USA and returns of the virus from the USA to certain countries including France.

Entities:  

Keywords:  COVID19; Clusters; Evolution; Origin; SARS-CoV-2; Transmission

Year:  2020        PMID: 33274614     DOI: 10.5802/crbiol.29

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  8 in total

1.  Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro.

Authors:  Leiping Zeng; Yanxia Liu; Xammy Huu Nguyenla; Timothy R Abbott; Mengting Han; Yanyu Zhu; Augustine Chemparathy; Xueqiu Lin; Xinyi Chen; Haifeng Wang; Draven A Rane; Jordan M Spatz; Saket Jain; Arjun Rustagi; Benjamin Pinsky; Adrianna E Zepeda; Anastasia P Kadina; John A Walker; Kevin Holden; Nigel Temperton; Jennifer R Cochran; Annelise E Barron; Michael D Connolly; Catherine A Blish; David B Lewis; Sarah A Stanley; Marie F La Russa; Lei S Qi
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

2.  Seroprevalence of SARS-COV-2 antibodies among health-care workers exposed to COVID-19 patients in a large reference hospital, Iran.

Authors:  Abdol Sattar Pagheh; Arghavan Asghari; Khadijeh Abrari Romenjan; Tahoora Mousavi; Farshid Abedi; Arash Ziaee; Hakime Malakimoghadam; Masood Ziaee
Journal:  Iran J Microbiol       Date:  2022-04

3.  Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern.

Authors:  Nariman Shahhosseini; George Giorgi Babuadze; Gary Wong; Gary P Kobinger
Journal:  Microorganisms       Date:  2021-04-26

4.  Heterogeneity of SARS-CoV-2 virus produced in cell culture revealed by shotgun proteomics and supported by genome sequencing.

Authors:  Fabrice Gallais; Olivier Pible; Jean-Charles Gaillard; Stéphanie Debroas; Hélène Batina; Sylvie Ruat; Florian Sandron; Damien Delafoy; Zuzana Gerber; Robert Olaso; Fabienne Gas; Laurent Bellanger; Jean-François Deleuze; Lucia Grenga; Jean Armengaud
Journal:  Anal Bioanal Chem       Date:  2021-05-20       Impact factor: 4.142

Review 5.  Covid-19 vaccines and variants of concern: A review.

Authors:  Ikbel Hadj Hassine
Journal:  Rev Med Virol       Date:  2021-11-09       Impact factor: 11.043

6.  Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir.

Authors:  Sven Ullrich; Kasuni B Ekanayake; Gottfried Otting; Christoph Nitsche
Journal:  Bioorg Med Chem Lett       Date:  2022-02-16       Impact factor: 2.823

7.  Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark.

Authors:  Thomas Y Michaelsen; Marc Bennedbæk; Lasse E Christiansen; Mia S F Jørgensen; Camilla H Møller; Emil A Sørensen; Simon Knutsson; Jakob Brandt; Thomas B N Jensen; Clarisse Chiche-Lapierre; Emilio F Collados; Trine Sørensen; Celine Petersen; Vang Le-Quy; Mantas Sereika; Frederik T Hansen; Morten Rasmussen; Jannik Fonager; Søren M Karst; Rasmus L Marvig; Marc Stegger; Raphael N Sieber; Robert Skov; Rebecca Legarth; Tyra G Krause; Anders Fomsgaard; Mads Albertsen
Journal:  Genome Med       Date:  2022-05-04       Impact factor: 15.266

Review 8.  SARS-CoV-2 Papain-Like Protease: Structure, Function and Inhibition.

Authors:  Sven Ullrich; Christoph Nitsche
Journal:  Chembiochem       Date:  2022-09-08       Impact factor: 3.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.